C. Decedue

发表

Solvent Removal and Spore Inactivation Directly in Dispensing Vials with Supercritical Carbon Dioxide and Sterilant

Wei Zhou, J. Howell, Fengui Niu, 2012, AAPS PharmSciTech.

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies

Thomas K. Schulz, K. Roby, K. Moore, 2015, Cancer Chemotherapy and Pharmacology.

Threonine deaminase from Salmonella typhimurium. Relationship between regulatory sites.

C. Decedue, J. Hofler, R. O. Burns, 1975, The Journal of biological chemistry.

Preclinical antitumor activity of a nanoparticulate SN38

David W. Henry, K. Roby, M. Al-kasspooles, 2013, Investigational New Drugs.

Purification and characterization of the extracellular proteinase of Serratia marcescens.

A. D. Larson, H. Braymer, C. Decedue, 1979, Biochimica et biophysica acta.

Molecular weight differences among potato peroxidases

R. Borchert, C. Decedue, S. J. Rogers, 1984 .

Solvent Removal and Spore Inactivation Directly in Dispensing Vials with Supercritical Carbon Dioxide and Sterilant

Wei Zhou, Fengui Niu, S. McCabe, 2012, AAPS PharmSciTech.

Immobilization of ascorbic acid oxidase

R. Borchardt, C. Bradberry, C. Decedue, 1982 .

Neplanocin A inhibition of S-adenosylhomocysteine hydrolase in Alcaligenes faecalis has no effect on growth of the microorganism.

R. Borchardt, C. Decedue, B. Keller, 1987, The Journal of antibiotics.

5-Quinone derivatives of 2'-deoxyuridine 5'-phosphate: inhibition and inactivation of thymidylate synthase, antitumor cell, and antiviral studies.

E. De Clercq, J. Balzarini, C. Decedue, 1987, Journal of medicinal chemistry.

Evaluation of intravenous and subcutaneous administration of a novel, excipient-free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasia.

J. Bryan, C. Henry, K. Selting, 2018, Veterinary and comparative oncology.

Evidence that somatomedin-C is degraded by the kidney and inhibits insulin degradation.

R. Furlanetto, J. V. Van Wyk, A. D'ercole, 1977, Endocrinology.

Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax.

K. Roby, P. Terranova, B. Subramaniam, 2008, Advances in experimental medicine and biology.

A synaptic membrane glycine-, glutamate- and thienylcyclohexylpiperidine-binding protein: isolation and immunochemical characterization

E. Michaelis, C. Decedue, Xingyu Chen, 1996, Neurochemistry International.

Response of HDL cholesterol, apoprotein A-I, and LCAT to exercise withdrawal.

J. Albers, T. R. Thomas, C. Decedue, 1985, Atherosclerosis.

The subunit structure of alpha-acetohydroxyacid isomeroreductase from Salmonella typhimurium.

J. Reynolds, G. H. Luginbuhl, C. Decedue, 1975, The Journal of biological chemistry.

Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines

T. Rosol, J. Bryan, K. Selting, 2013, Investigational New Drugs.

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs

C. Henry, K. Selting, C. Decedue, 2011, International Journal of Nanomedicine.

Purification, Biochemical Characterization, Binding Activity, and Selectivity of a Glutamate Binding Protein from Bovine Brain

C. Decedue, N. Galton, Elias K. Michaelis, 1984, Journal of neurochemistry.

Paclitaxel nanoparticles: Production using compressed CO2 as antisolvent : Characterization and animal model studies

K. Roby, B. Subramaniam, R. Rajewski, 2006 .